Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-13
1996-05-07
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514825, 514826, 514863, A61K 3138
Patent
active
055147046
ABSTRACT:
A method of inhibiting leukotrienes comprising administering to a mammal in need thereof an effective amount of a compound having the formula ##STR1## wherein R.sub.1 and R.sub.2 are independently hydrogen or C.sub.1 -C.sub.6 alkyl;
REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4380635 (1983-04-01), Peters
patent: 4418068 (1983-11-01), Jones
patent: 4663347 (1987-05-01), Atkinson
patent: 4849445 (1989-07-01), Schaub
patent: 4863958 (1989-09-01), Belanger et al.
patent: 4963580 (1990-10-01), Zambias et al.
patent: 5093351 (1992-03-01), Batt
patent: 5389670 (1995-02-01), Fontana
patent: 5391557 (1995-02-01), Cullinan et al.
Brooks, et al., Drugs of the Future, 18(7), 616-618 (1993).
Carlson Donald G.
Cullinan George J.
Fahey Kennan J.
Jackson William T.
Roehm Neal W.
Boone David E.
Eli Lilly and Company
Lambkin Deborah
Raymond Richard L.
Sales James J.
LandOfFree
Benzothiophenes to inhibit leukotrienes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiophenes to inhibit leukotrienes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiophenes to inhibit leukotrienes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1227572